Eye movement test for vision loss from pituitary tumors
Part of Brain & nervous system, Cancer, Eyes & vision, Hormones & metabolism clinical trials.
This study tests a new way to measure side vision using eye movements. It might be helpful for people with tumors near the pituitary gland who have vision problems, by making the vision test easier and more comfortable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a tumor near the pituitary gland (at the base of the brain).
- You have some loss of side vision, as shown by a recent eye test called a visual field test.
- You do not have other brain or nerve conditions (like multiple sclerosis or Parkinson's disease).
- You do not have eye diseases not caused by your tumor (like cataracts or glaucoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-invasive way to monitor pressure inside the skull during brain tumor surgery. It may help guide treatment without the need for invasive monitors.
This trial tests a nerve stimulation treatment during surgery to remove certain brain tumors (like pituitary adenomas) to help prevent vision problems that can happen after the operation. It may help preserve your eyesight.
This study tests a non-invasive brain stimulation treatment to see if it can improve peripheral (side) vision in people with open-angle or normal-tension glaucoma. It targets people whose central vision is still relatively preserved but whose side vision has a measurable “gap” on vision testing.
This study tests whether a screening program can find and treat vision problems caused by a stroke. The goal is to help you recover more of your visual field (the area you can see).
This study uses eye movement tests to help doctors tell apart different causes of sudden dizziness or vertigo. It may help improve diagnosis and treatment for people with acute vestibular syndrome.
This pilot study tests a new portable device for measuring your field of vision during a glaucoma clinic visit. You may benefit from a quicker or more convenient test.
Hear when a new Pituitary Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.